CGN
中广核
CGNCompany
中广核
No graph yet
Mentioned in 3 articles
Coverage
Linear Capital Leads Angel Round Investment in Yuansuan Technology, Which Completes Hundreds of Millions of Yuan in Series C1 Funding
Recently, Yuansuan Technology, a Linear Capital angel-round lead investment, completed a Series C1 raise of several hundred million RMB. This round was jointly invested by CITIC Securities, Zhejiang Financial Holdings, and others, with existing shareholders including CDH Venture Capital continuing to increase their stakes.
线性资本·Trekking to Riyadh
Opportunity, wealth, and a surging tide of people.
暗涌Waves·Everything Has Two Sides: How Can "Nuclear Radiation" Be Used to Make Anti-Cancer Drugs? | FreeS Report 28
Now is the spring of radiopharmaceuticals.
峰瑞资本·
